Association of ankylosing spondylitis with cardiovascular disease: a bidirectional two-sample mendelian randomization study

P Liu, J Shang, Z Qi, S Qiu, X Lai, L Shi, Z Zhang… - Frontiers in …, 2024 - frontiersin.org
Backgrounds Current observational investigations hint at a potential linkage between
ankylosing spondylitis and cardiovascular wellness. However, the nature of this causality …

The association of tumor necrosis factor inhibitor use with incident hypertension in ankylosing spondylitis: data from the psoas cohort

JW Liew, SR Jafarzadeh, M Dubreuil… - The Journal of …, 2022 - jrheum.org
Objective Individuals with ankylosing spondylitis (AS) have a greater cardiovascular (CV)
risk than those in the general population. The effect of tumor necrosis factor inhibitors …

Vascular involvement in axial spondyloarthropathies

C Prati, C Demougeot, X Guillot, M Sondag… - Joint Bone Spine, 2019 - Elsevier
Ankylosing spondylitis (AS) is a chronic inflammatory joint disease that involves the
entheses, causing inflammatory pain and functional impairments. Patients may experience …

Effects of ankylosing spondylitis on cardiovascular disease: aMendelian randomization study

L Xiao, S Lin, F Zhan - Frontiers in Genetics, 2024 - frontiersin.org
Objective Accumulating evidence suggests that patients with ankylosing spondylitis (AS)
have an elevated risk for cardiovascular disease (CVD) and cardiovascular death, however …

Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies

H Gouze, P Aegerter, Y Gouyette, M Breban… - …, 2024 - academic.oup.com
Abstract Objectives Spondyloarthritis (SpA) and psoriatic arthritis (PsA) represent two
frequent inflammatory rheumatic disorders, characterized by an increased burden on quality …

Radiographic progression is associated with increased cardiovascular risk in patients with axial spondyloarthritis

KY Kang, YH Her, JH Ju, YS Hong… - Modern …, 2016 - academic.oup.com
Objectives: To compare the cardiovascular disease (CVD) risk between axial
spondyloarthritis (axSpA) patients and matched controls, and to identify factors associated …

[HTML][HTML] Риск появления ишемической болезни сердца у больных анкилозирующим спондилитом (болезнью Бехтерева) и псориатическим артритом по …

ИЗ Гайдукова, АП Ребров - Клиницист, 2016 - cyberleninka.ru
Цель исследования–оценка частоты появления новых случаев ишемической болезни
сердца (ИБС) у больных анкилозирующим спондилитом (АС) и псориатическим …

Recommendations for the management of comorbidity in patients with axial spondyloarthritis in clinical practice

C González, RC Rodríguez, JC Torre-Alonso… - … Clínica (English Edition), 2018 - Elsevier
Objectives To identify priorities among comorbidities in axial spondyloarthritis (AxSpA) and
recommend how to follow them from an eminently practical perspective. Methods A …

Cardiovascular risk scores in axial spondyloarthritis versus the general population: a cross-sectional study

JW Liew, JD Reveille, M Castillo, H Sawhney… - The Journal of …, 2021 - jrheum.org
Objective. Cardiovascular (CV) morbidity and mortality are increased in axial
spondyloarthritis (axSpA). We conducted a cross-sectional study evaluating the 10-year …

Comorbidities in spondyloarthritis

A Danve, SP Raychaudhuri - Current Treatment Options in Rheumatology, 2017 - Springer
Opinion statement Spondyloarthritides (SpA) are a group of immune-mediated inflammatory
diseases that affect the axial and peripheral skeleton as well as the skin, eye, and gut …